MptpB-IN-3
MptpB-IN-3 is a selective inhibitor of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) with an IC50 of 0.19 μM. MptpB-IN-3 blocks MptpB-mediated inhibition of the macrophage MAPK pathway and restores the phosphorylation levels of Erk1/2 and p38. MptpB-IN-3 exhibits direct anti-tuberculosis activity against Mycobacterium tuberculosis and reduces the Mycobacterium tuberculosis load in mouse macrophages. MptpB-IN-3 can be used for tuberculosis research.
For research use only. We do not sell to patients.
- CAS No.: 3104354-58-4
- Formula: C22H21FN4O7S2
- Molecular Weight:536.55
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
ERK1 |
ERK2 |
In Vitro
MptpB-IN-3 (Compound 4) inhibits purified recombinant human PTP1B with an IC50 of 65.61 μM, demonstrating 345-fold selectivity for Mycobacterium tuberculosis MptpB over the human phosphatase[1].
MptpB-IN-3 inhibits the growth of drug-sensitive Mycobacterium tuberculosis H37Rv with a MIC of 1.94 μg/mL[1].
MptpB-IN-3 inhibits the growth of multi-drug-resistant Mycobacterium tuberculosis strains 13946 and 14862 with MICs of 3.80 μg/mL and 4.60 μg/mL, respectively, but is inactive against a pretomanid-resistant strain (MIC >32 μg/mL)[1].
MptpB-IN-3 (0.26-64 μg/mL; 48 h) exhibits no cytotoxicity against Vero and J774A.1 macrophage cells (IC50 >64 μg/mL) and low cytotoxicity against HepG2 cells (IC50 = 55.92 μg/mL)[1].
MptpB-IN-3 (1-10 μg/mL) reduces Mycobacterium tuberculosis burden in infected J774A.1 macrophages in a dose-dependent manner, and exhibits greater potency than Rifampicin and PA-824 at equivalent doses[1].
MptpB-IN-3 (5-20 μM; 3 h) specifically restores Erk1/2 and p38 phosphorylation in IFN-γ-stimulated Raw264.7 cells overexpressing wild-type Mycobacterium tuberculosis MptpB, reversing MptpB-mediated suppression of the MAPK pathway[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:IFN-γ-stimulated Raw264.7 cells overexpressing wild-type MptpB or catalytically inactive MptpB/C160S
-
Concentration:5, 10 and 20 μM
-
Incubation Time:1 h (preincubation); 2 h (IFN-γ stimulation)
-
Result:Restored phosphorylation of Erk1/2 and p38 in cells expressing wild-type MptpB, reversing MptpB-mediated suppression of the MAPK pathway; no notable changes were observed in vector-control or MptpB/C160S-expressing cells.
Parmacokinetics
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3104354-58-4
-
Molecular Weight 536.55
-
Formula C22H21FN4O7S2
-
SMILES
CCCC[C@H](N1C(/C(SC1=S)=C/C2=CC(F)=C(C=C2)O[C@@H]3COC4=NC([N+]([O-])=O)=CN4C3)=O)C(O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- MptpB-IN-3
- 3104354-58-4
- Bacterial
- Phosphatase
- p38 MAPK
- ERK
- Mycobacterium tuberculosis protein tyrosine phosphatase B
- Mycobacterium tuberculosis H37Rv
- J774A.1 macrophage cells
- p38
- human PTP1B
- Mycobacterium tuberculosis
- Erk1/2
- mouse macrophages
- multi-drug-resistant Mycobacterium tuberculosis
- macrophage MAPK pathway
- Inhibitor
- inhibitor
- inhibit